Source link : https://newshealth.biz/health-news/immunotherapy-highly-active-in-small-study-of-advanced-ctcl/
(MedPage Today) — HOUSTON — Patients with advanced or refractory cutaneous T-cell lymphoma (CTCL) achieved near-100% disease control with single-agent immunotherapy or an immuno-oncology (IO) combination, a small randomized trial showed. Eight… Source link : https://www.medpagetoday.com/meetingcoverage/soho/117343 Author : Publish date : 2025-09-06 20:00:00 Copyright for syndicated content belongs to the linked Source.
The post Immunotherapy Highly Active in Small Study of Advanced CTCL first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-06 20:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8